Brudnick Richard 4
4 · Prime Medicine, Inc. · Filed Feb 23, 2024
Insider Transaction Report
Form 4
Brudnick Richard
Chief Business Officer
Transactions
- Award
Stock Option (right to buy)
2024-02-21+135,747→ 135,747 totalExercise: $8.49Exp: 2034-02-21→ Common Stock (135,747 underlying)
Footnotes (1)
- [F1]1/48th of the shares underlying this option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of February 21, 2024, subject to the Reporting Person's continued service on each such vesting date.